Answers are grounded in this paper and cite their sources.
T-lymphocytes within metastatic tumors and inhibition of metastatic growth. The expression of CRT and the release of HMGB1 from tumor tissues were increased in the ADM-treated groups. Treatment with DCs and ADM resulted in the highest serum interferon-γ levels. Combining ADM, which can induce immunogenic cell death, with DCs enhanced the systemic immune response. The findings of the present study provide further support for the continued development of antitumor agents that induce cell death and the immune response to target osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: